 SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores
SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores
Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores
Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores
IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores
Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores 
              The Board of Directors of Bafna Pharmaceuticals Ltd at its meeting held on June 17, 2016, considered and approved the proposal for Allotment of Equity Shares of 10,00,000 to Promoters and 30,00,000 Equity Shares to External investors (Non-Promoter) under Preferential allotment basis through Postal Ballot Process.
Shares of BAFNA PHARMACEUTICALS LTD. was last trading in BSE at Rs.30.15 as compared to the previous close of Rs. 28.8. The total number of shares traded during the day was 90209 in over 641 trades.
The stock hit an intraday high of Rs. 31.35 and intraday low of 29.6. The net turnover during the day was Rs. 2762364.